WOONSOCKET, R.I., Nov. 6, 2014 /PRNewswire/ –CVS Health (NYSE: CVS) today announced the kickoff and major expansion of Project Health, its annual free health screening campaign, at select CVS/pharmacy locations. Over the next four months, the Project Health wellness program will deliver more than $14 million worth of free health services to multicultural communities with […]
High Rates of Viral Suppression and Improved Renal and Bone Safety Demonstrated in Phase 3 Studies First of Several TAF-Based Single Tablet Regimens Being Evaluated by Gilead FOSTER CITY, Calif.–(BUSINESS WIRE)–Nov. 6, 2014– Gilead Sciences, Inc. (NASDAQ: GILD) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug […]
15 presentations focus on next-generation sequencing-based MRD detection in a range of blood cancers, including diffuse large B-cell lymphoma and multiple myeloma SOUTH SAN FRANCISCO, Calif. NOVEMBER 6, 2014 – Sequenta, Inc. and its academic collaborators will present data on the ClonoSIGHT™ minimal residual disease (MRD) test in one oral and 14 poster presentations at […]
CHESHIRE, Conn. November 6, 2014 –(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that researchers will present data from clinical studies of Soliris® (eculizumab) in patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), two life-threatening and ultra-rare diseases caused by chronic uncontrolled complement activation, as well as data from the Global aHUS […]
GE Healthcare supporting a number of European hospitals to improve efficiency and patient-care via innovative integrated care solutions Birmingham, 4 November 2014 – GE Healthcare is sharing information on several partnerships focusing on integrated care at EHI Live on the 4-5 November in Birmingham, UK. In North Wales, Betsi Cadwaladr University Health Board is to […]
Study Failed to Meet Secondary Endpoint of Overall Survival THOUSAND OAKS, Calif., Nov. 4, 2014 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the top-line secondary endpoint results of overall survival from the Phase 3 TRINOVA-1 trial in women with recurrent platinum-resistant ovarian cancer. The study, which evaluated trebananib plus paclitaxel versus placebo plus paclitaxel, did not […]
WOONSOCKET, R.I., Nov. 3, 2014 /PRNewswire/ –CVS/pharmacy, the retail division of CVS Health (NYSE: CVS), today announced an in-store fundraising campaign to help raise funds to support cancer research. Now through November 22, CVS/pharmacy customers will have the opportunity to support Stand Up To Cancer (SU2C) at the register in stores nationwide and online at […]
WOONSOCKET, R.I., Nov. 3, 2014 /PRNewswire/ — To kick off the holiday season, CVS/pharmacy today announced the return of its popular “Free Gift Card” promotion, an offer designed to allow customers the opportunity to receive free gift cards by shopping for everyday essentials at store locations nationwide. Now through November 22, ExtraCare Rewards program members […]
PORTLAND, OCTOBER 31, 2014 – Healthiest Employers, a data analytics company that recognizes healthy workplaces, has ranked Cambia Health Solutions second among Oregon large employers competing in the annual statewide event. “We are honored to be recognized as one of the healthiest employers in Oregon,” says Mark Stimpson, vice president of human resources. “Cambia has been […]
WOONSOCKET, R.I., Oct. 31, 2014 /PRNewswire/ –New research from CVS Health (NYSE: CVS) finds starting a new diabetes patient on metformin, a generic oral diabetes medicine that helps control blood sugar levels, reduced the need to add on additional treatments to control the condition over time. Although there are many classes of oral diabetes medications, […]
